222 related articles for article (PubMed ID: 25619781)
1. Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.
Sheeran PS; Rojas JD; Puett C; Hjelmquist J; Arena CB; Dayton PA
Ultrasound Med Biol; 2015 Mar; 41(3):814-31. PubMed ID: 25619781
[TBL] [Abstract][Full Text] [Related]
2. Pulse sequences for uniform perfluorocarbon droplet vaporization and ultrasound imaging.
Puett C; Sheeran PS; Rojas JD; Dayton PA
Ultrasonics; 2014 Sep; 54(7):2024-33. PubMed ID: 24965563
[TBL] [Abstract][Full Text] [Related]
3. Vaporization Detection Imaging: A Technique for Imaging Low-Boiling-Point Phase-Change Contrast Agents with a High Depth of Penetration and Contrast-to-Tissue Ratio.
Rojas JD; Dayton PA
Ultrasound Med Biol; 2019 Jan; 45(1):192-207. PubMed ID: 30482709
[TBL] [Abstract][Full Text] [Related]
4. Optimizing Acoustic Activation of Phase Change Contrast Agents With the Activation Pressure Matching Method: A Review.
Rojas JD; Dayton PA
IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):264-272. PubMed ID: 27740481
[TBL] [Abstract][Full Text] [Related]
5. Slow-Flow Ultrasound Localization Microscopy Using Recondensation of Perfluoropentane Nanodroplets.
Burgess MT; Aliabouzar M; Aguilar C; Fabiilli ML; Ketterling JA
Ultrasound Med Biol; 2022 May; 48(5):743-759. PubMed ID: 35125244
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Assessment of the Potential for Renal Bio-Effects from the Vaporization of Perfluorocarbon Phase-Change Contrast Agents.
Nyankima AG; Rojas JD; Cianciolo R; Johnson KA; Dayton PA
Ultrasound Med Biol; 2018 Feb; 44(2):368-376. PubMed ID: 29254872
[TBL] [Abstract][Full Text] [Related]
7. Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging.
Sheeran PS; Wong VP; Luois S; McFarland RJ; Ross WD; Feingold S; Matsunaga TO; Dayton PA
Ultrasound Med Biol; 2011 Sep; 37(9):1518-30. PubMed ID: 21775049
[TBL] [Abstract][Full Text] [Related]
8. Fluorous-phase iron oxide nanoparticles as enhancers of acoustic droplet vaporization of perfluorocarbons with supra-physiologic boiling point.
Vezeridis AM; de Gracia Lux C; Barnhill SA; Kim S; Wu Z; Jin S; Lux J; Gianneschi NC; Mattrey RF
J Control Release; 2019 May; 302():54-62. PubMed ID: 30928487
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous Nucleation of Stable Perfluorocarbon Emulsions for Ultrasound Contrast Agents.
Li DS; Schneewind S; Bruce M; Khaing Z; O'Donnell M; Pozzo L
Nano Lett; 2019 Jan; 19(1):173-181. PubMed ID: 30543289
[TBL] [Abstract][Full Text] [Related]
10. Investigation of vaporized submicron perfluorocarbon droplets as an ultrasound contrast agent.
Reznik N; Williams R; Burns PN
Ultrasound Med Biol; 2011 Aug; 37(8):1271-9. PubMed ID: 21723449
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Molecular Imaging Using Low-Boiling-Point Phase-Change Contrast Agents: A Proof of Concept Study.
Rojas JD; Dayton PA
Ultrasound Med Biol; 2019 Jan; 45(1):177-191. PubMed ID: 30318123
[TBL] [Abstract][Full Text] [Related]
12. Methods of Generating Submicrometer Phase-Shift Perfluorocarbon Droplets for Applications in Medical Ultrasonography.
Sheeran PS; Matsuura N; Borden MA; Williams R; Matsunaga TO; Burns PN; Dayton PA
IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):252-263. PubMed ID: 27775902
[TBL] [Abstract][Full Text] [Related]
13. Phase-change contrast agents for imaging and therapy.
Sheeran PS; Dayton PA
Curr Pharm Des; 2012; 18(15):2152-65. PubMed ID: 22352770
[TBL] [Abstract][Full Text] [Related]
14. On the acoustic properties of vaporized submicron perfluorocarbon droplets.
Reznik N; Lajoinie G; Shpak O; Gelderblom EC; Williams R; de Jong N; Versluis M; Burns PN
Ultrasound Med Biol; 2014 Jun; 40(6):1379-84. PubMed ID: 24462162
[TBL] [Abstract][Full Text] [Related]
15. More Than Bubbles: Creating Phase-Shift Droplets from Commercially Available Ultrasound Contrast Agents.
Sheeran PS; Yoo K; Williams R; Yin M; Foster FS; Burns PN
Ultrasound Med Biol; 2017 Feb; 43(2):531-540. PubMed ID: 27727022
[TBL] [Abstract][Full Text] [Related]
16. Bubble Inflation Using Phase-Change Perfluorocarbon Nanodroplets as a Strategy for Enhanced Ultrasound Imaging and Therapy.
Brambila CJ; Lux J; Mattrey RF; Boyd D; Borden MA; de Gracia Lux C
Langmuir; 2020 Mar; 36(11):2954-2965. PubMed ID: 32090572
[TBL] [Abstract][Full Text] [Related]
17. Effects of microchannel confinement on acoustic vaporisation of ultrasound phase change contrast agents.
Lin S; Zhang G; Leow CH; Tang MX
Phys Med Biol; 2017 Aug; 62(17):6884-6898. PubMed ID: 28718774
[TBL] [Abstract][Full Text] [Related]
18. Impact of Encapsulation on in vitro and in vivo Performance of Volatile Nanoscale Phase-Shift Perfluorocarbon Droplets.
Yoo K; Walker WR; Williams R; Tremblay-Darveau C; Burns PN; Sheeran PS
Ultrasound Med Biol; 2018 Aug; 44(8):1836-1852. PubMed ID: 29908752
[TBL] [Abstract][Full Text] [Related]
19. Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells.
Hadinger KP; Marshalek JP; Sheeran PS; Dayton PA; Matsunaga TO
Ultrasound Med Biol; 2018 Dec; 44(12):2728-2738. PubMed ID: 30228045
[TBL] [Abstract][Full Text] [Related]
20. Thermal and Acoustic Stabilization Of Volatile Phase-Change Contrast Agents Via Layer-By-Layer Assembly.
Alcaraz PE; Davidson SJ; Shreeve E; Meuschke R; Romanowski M; Witte RS; Porter TR; Matsunaga TO
Ultrasound Med Biol; 2023 May; 49(5):1058-1069. PubMed ID: 36797095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
